Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update

Inflamm Bowel Dis. 2024 Jan 5;30(1):146-149. doi: 10.1093/ibd/izad055.

Authors

Monica E W Derks¹, Lisa M A van Lierop^{1

2}, Maarten Te Groen¹, Chantal C H J Kuijpers³, Iris D Nagtegaal⁴, Frank Hoentjen^{1

2}

Affiliations

¹ Inflammatory Bowel Disease Center, Department of Gastroenterology, Radboud University Medical Center, Nijmegen, the Netherlands.
² Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
³ PALGA Foundation, Houten, the Netherlands.
⁴ Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

No abstract available

Keywords: COVID-19; CRC; Diagnosis; Endoscopy; dysplasia; healthcare utilization; inflammatory bowel disease; surgery.

MeSH terms

COVID-19* / epidemiology
Humans
Inflammatory Bowel Diseases* / epidemiology
Inflammatory Bowel Diseases* / therapy
Pandemics
Patient Acceptance of Health Care
SARS-CoV-2